Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339426 (US10202330, Example 18) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339419 (US10202330, Example 10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339420 (US10202330, Example 11) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339411 (US10202330, Example 2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339410 (US10202330, Example 1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339427 (US10202330, Example 20) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339410 (US10202330, Example 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339425 (US10202330, Example 16) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339424 (US10202330, Example 15) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339424 (US10202330, Example 15) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339423 (US10202330, Example 14) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339422 (US10202330, Example 13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339421 (US10202330, Example 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339418 (US10202330, Example 9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339417 (US10202330, Example 8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339416 (US10202330, Example 7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339415 (US10202330, Example 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339414 (US10202330, Example 5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339413 (US10202330, Example 4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM339412 (US10202330, Example 3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339427 (US10202330, Example 20) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339412 (US10202330, Example 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339417 (US10202330, Example 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339425 (US10202330, Example 16) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339418 (US10202330, Example 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339418 (US10202330, Example 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339425 (US10202330, Example 16) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339419 (US10202330, Example 10) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339419 (US10202330, Example 10) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339411 (US10202330, Example 2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339420 (US10202330, Example 11) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339420 (US10202330, Example 11) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339411 (US10202330, Example 2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339421 (US10202330, Example 12) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339421 (US10202330, Example 12) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339427 (US10202330, Example 20) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339422 (US10202330, Example 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339422 (US10202330, Example 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339426 (US10202330, Example 18) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339423 (US10202330, Example 14) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339417 (US10202330, Example 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339412 (US10202330, Example 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339410 (US10202330, Example 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339415 (US10202330, Example 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339415 (US10202330, Example 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339424 (US10202330, Example 15) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339414 (US10202330, Example 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] A (Homo sapiens (Human)) | BDBM339414 (US10202330, Example 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339426 (US10202330, Example 18) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Amine oxidase [flavin-containing] B (Homo sapiens (Human)) | BDBM339413 (US10202330, Example 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ORYZON GENOMICS, SA US Patent | Assay Description Briefly, a fixed amount of MAO (0.25 μg for MAO-A and 0.5 μg for MAO-B) was incubated on ice for 15 minutes in the reaction buffer, in the ... | US Patent US10202330 (2019) BindingDB Entry DOI: 10.7270/Q29C70KG | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 54 total ) | Next | Last >> |